KORU Medical Systems, Inc. (NASDAQ:KRMD – Get Free Report) saw a significant increase in short interest in October. As of October 15th, there was short interest totalling 504,300 shares, an increase of 10.3% from the September 30th total of 457,400 shares. Currently, 1.2% of the company’s stock are short sold. Based on an average daily volume of 68,500 shares, the days-to-cover ratio is currently 7.4 days.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on the stock. B. Riley initiated coverage on shares of KORU Medical Systems in a research report on Thursday, July 25th. They set a “buy” rating and a $4.00 price target for the company. Piper Sandler raised their price objective on KORU Medical Systems from $2.50 to $3.00 and gave the stock an “overweight” rating in a research note on Thursday, August 8th.
Get Our Latest Stock Analysis on KORU Medical Systems
Hedge Funds Weigh In On KORU Medical Systems
KORU Medical Systems Price Performance
NASDAQ:KRMD traded up $0.29 during mid-day trading on Thursday, reaching $2.92. 51,234 shares of the stock were exchanged, compared to its average volume of 117,726. The company has a current ratio of 3.77, a quick ratio of 3.27 and a debt-to-equity ratio of 0.01. The business has a fifty day moving average price of $2.55 and a 200 day moving average price of $2.41. KORU Medical Systems has a 1-year low of $1.98 and a 1-year high of $3.09. The firm has a market capitalization of $133.90 million, a PE ratio of -10.43 and a beta of 0.42.
KORU Medical Systems (NASDAQ:KRMD – Get Free Report) last issued its earnings results on Wednesday, August 7th. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.02. The firm had revenue of $8.43 million during the quarter, compared to analysts’ expectations of $7.52 million. KORU Medical Systems had a negative net margin of 38.16% and a negative return on equity of 20.82%. During the same period last year, the firm posted ($0.05) earnings per share. Research analysts expect that KORU Medical Systems will post -0.13 earnings per share for the current fiscal year.
KORU Medical Systems Company Profile
KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.
See Also
- Five stocks we like better than KORU Medical Systems
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- NYSE Stocks Give Investors a Variety of Quality Options
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Pros And Cons Of Monthly Dividend Stocks
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.